会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • ROBOT SYSTEM REMOTE-CONTROLLED THROUGH CELLPHONE EARPHONE INTERFACE
    • 机器人系统通过电话耳机接口远程控制
    • WO2014161481A3
    • 2014-11-20
    • PCT/CN2014074570
    • 2014-04-01
    • LI BO
    • LI BO
    • G05B19/04
    • B25J9/1689G05B2219/35446G05D1/0016G05D2201/02
    • The present application addresses a robot system remote-controlled by means of a cellphone earphone or similar interface, and primarily constitutes a communication and control system the primary function whereof is to use a master control cellphone terminal and specific software to control another slave cellphone terminal over a wireless or wired network and then, by means of the earphone and other data interfaces of the controlled cellphone terminal, to output a control signal and to convert said control signal by means of a signal processing module into robot body circuit signals to control the movement of the movable components of the robot.
    • 本申请涉及通过手机耳机或类似接口远程控制的机器人系统,并且主要构成通信和控制系统,其主要功能是使用主控蜂窝电话终端和特定软件来控制另一个从手机终端 无线或有线网络,然后借助于受控手机终端的耳机和其他数据接口输出控制信号,并通过信号处理模块将所述控制信号转换成机器人电路信号,以控制移动 的机器人的可移动部件。
    • 6. 发明申请
    • COMPOSITIONS AND METHODS TO PREVENT CELL TRANSFORMATION AND CANCER METASTASIS
    • 预防细胞转化和癌症转移的组合物和方法
    • WO2012112865A3
    • 2012-10-04
    • PCT/US2012025603
    • 2012-02-17
    • UNIV CORNELLCERIONE RICKANTONYAK MARCCERIONE KRISTIN WILSONLI BO
    • CERIONE RICKANTONYAK MARCCERIONE KRISTIN WILSONLI BO
    • G01N33/53
    • G01N33/6893G01N33/5076G01N33/57484
    • Provided are methods for characterizing microvesicles or other membranous structures. The methods involve assaying samples for microvesicles or other membranous structures, and include in certain aspects determining the presence or absence of tissue transglutaminase (tTG) and/or cross-linked fibronection (FN). The microvesicles or other membranous structures can be separated from a sample using recombinant tTG or a derivative of it, or tTG or FN binding partners. Also provided are methods for inhibiting the transfer of cargo from microvesicles which contain tTG to one or more cells. This involves administering to the individual a tTG inhibitor, such as a cell-impermeable tTG inhibitor. Also provided are compositions which contain a population of microvesicles or other membranous structures, where the population is attached to tTG or a derivative thereof, or to tTG or an FN binding partner. Kits which contain reagents and other components for carrying out the method are also provided.
    • 提供了表征微泡或其他膜结构的方法。 该方法包括测定样品的微泡或其他膜结构,并且在某些方面包括确定组织转谷氨酰胺酶(tTG)和/或交联纤连蛋白(FN)的存在或不存在。 可使用重组tTG或其衍生物或tTG或FN结合配偶体将微泡或其他膜结构与样品分离。 还提供了用于抑制货物从含有tTG的微泡转移到一个或多个细胞的方法。 这涉及向个体施用tTG抑制剂,例如细胞不可渗透的tTG抑制剂。 还提供了含有一群微泡或其他膜结构的组合物,其中群体与tTG或其衍生物或tTG或FN结合配偶体连接。 还提供了包含用于实施该方法的试剂和其他组分的试剂盒。